The latest chapter in Human Genome Sciences’ battle to fend off a hostile takeover bid by British pharma giant GlaxoSmithKline played out in a Rockville courtroom Thursday morning.
A Montgomery County Circuit Court judge shot down an HGS shareholder’s request for a temporary restraining order to invalidate the “poison pill” the Rockville biotech enacted last month to make it a less attractive acquisition target.
{iframe}http://www.gazette.net/article/20120531/NEWS/705319778/-1/judge-sides-with-hgs-on-poison-pill&template=gazette{/iframe}